Clinical Trial Update: Treatment for Subjects With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a treatment for Non-Hodgkin lymphoma sponsored by Amgen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Amgen | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED